Media Room
19 November 2024
The Lifecycle of Radiopharmaceuticals: From Research to Clinical Use
Radiopharmaceuticals are drugs that contain radionuclides. They are primarily used for two main purposes: diagnostic procedures and treatment assessments through imaging. The radiation detected by nuclear medicine cameras helps doctors observe and analyse how the human body functions. Additionally, they...
11 October 2024
Lemer Pax helps you fight MusculoSkeletal Disorders (MSD)
The STOP MSD product range, designed to ensure operator safety and maximum comfort, will be presented at the upcoming European Association of Nuclear Medicine (EANM) congress, Europe’s premier annual nuclear medicine event, held from 19 to 23 October 2024 in...
26 September 2024
Radioactive waste management: for secure storage and optimised decay
Radioactive waste are radionuclide-contaminated fluids, generally coming from radioactively contaminated sinks, showers and toilets in Nuclear Medicine departments, as well as from shielded rooms used for diagnostic and therapeutic treatments. They come not only from hospitals, but also from nuclear...
29 August 2024
Comparison of injection systems for luteinized therapies: Plum 360™ pump assembly vs Theranojet®ARA
The increase in requests for luteinized therapy has led to questions about the most appropriate injection system. Lemer Pax offers a new system: the Theranojet®ARA.
The aim was to see whether or not the Lemer Pax device improved ergonomics, radiation protection or performance.
3 July 2024
Lemer Pax, sponsor of the WASZP 2024 French Championship
From 4 to 7 July, the Yacht Club de la Grande Motte (France), in partnership with the Centre d’Entraînement Méditerranée, will be hosting the French championship for Waszp, the new foiling flying dinghy. Another innovation, and a world first in...
27 June 2024
RadioPharmaceutical Therapy (RPT): a major advance in cancer treatment
RadioPharmaceutical Therapy (RPT) represents a significant advance in the fight against cancer. Although this innovative technique currently accounts for only a small proportion of cancer treatments, RPT offers new perspectives for treating malignant tumours by precisely targeting cancer cells while...
24 April 2024
Lemer Pax signs a partnership for distributing ICUMedical’s Plum 360™ pump for the french nuclear medicine market
On 1 January 2024, Lemer Pax, world leader in innovation in the field of radiation protection, and ICU Medical, world leader in infusion systems, infusion consumables and intensive care products, signed a partnership for distributing the Plum 360TM pump for...
31 January 2024
2023 Retrospective
Ongoing projects, success stories, technological innovations, events and business news… our interactive retrospective takes a look back at the highlights of the past year! Once again, the Lemer Pax teams wish you all the best for 2024! [INSTRUCTIONS] You can navigate...
19 December 2023
Lemer Pax and SNOLAB: Act II before the underground installation
In late December 2019, Lemer Pax delivered an ultra-low background noise shielding structure to the Canadien Super CDMS (Super Cryogenic Dark Matter Search) Snolab project. The scientific focus of this project revolves around astroparticle physics, particularly neutrinos and dark matter....
14 November 2023
Nuclear fusion, the example of ITER
ITER (International Thermonuclear Experimental Reactor, also meaning "path" in Latin) is a scientific programme and challenge. Its aim is to carry out controlled nuclear fusion experiments at unprecedented levels of power and duration, and to understand the dynamics involved.
Due to its size, the ITER tokamak will be the most powerful tokamak ever built.
To achieve this objective, it will be necessary to create neutron-absorbing materials in the mortar family: lightweight and hydrogen-rich.
10 October 2023
3 questions for … Cécile Arbouille, Senior Executive Advisor, Nuclear Generation Division / EDF
We asked Cécile Arbouille, Delegate to the Nuclear Generation Division at EDF, 3 questions. In charge of Industrial Policy and Supplier Relations, she has a central role to play in the challenge of ensuring the secure, available and cost-effective operation of France’s fleet of nuclear power plants.
8 September 2023
1st Lutetium-177 injections with the Theranojet®ARA shielded injection system at the Beaujon AP-HP hospital, Paris, France
On August 3, the Beaujon AP-HP hospital Nuclear Medicine department AP-HP (Assistance Publique – Hôpitaux de Paris), located in Clichy, in Paris (France), successfully injected its first treatments with Lutathera using the new Theranojet®ARA shielded injection system. The result of...
26 August 2023
Lemer Pax launches OSIRIS, its Lean management transformation with EliteOrga
In a context of major growth for the company, particularly in a field of activity requiring a large dose of rigour and organization, Lemer Pax decided in 2019 to start, with EliteOrga, a major organizational transformation project. These important developments,...
15 June 2023
Lemer Pax and CCNuclear announce the creation of Lemer Pax America
The creation of the Canadian company Lemer Pax America will be officially announced at the 35th edition of the SNMMI (Society of Nuclear Medicine & Molecular Imaging) in Chicago on June 24-27 by Pierre-Marie Lemer, President of Lemer Pax, and...
27 April 2023
The Radiation Protection Advisor (RPA)
The immanente guarantee of radiation protection
By anticipating the risks of exposure to ionizing radiation, the Radiation Protection Advisor (RPA) applies the safety rules defined by the Labour Code and the Public Health Code and implements the means to guarantee optimal radiation protection (ALARA principle). Here at Lemer Pax, the Radiation Protection Advisor intervenes in all areas related to radiation protection (medical, industry, etc.) and brings their expertise to the development of the innovative equipment of tomorrow.
16 February 2023
Lemer Pax in the race to develop radiopharmacy
Radiopharmacy is the set of human and material resources necessary for the exercise of this activity, which uses radioactive sources for the preparation of radiopharmaceutical drugs used in Nuclear Medicine.
France
